BioLineRx Reports Year End 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. BA
4. HOOD
5. SPY
6. CDNS
7. ANT
8. META
9. STX
10. INTC

Go back to BioLineRx Reports Year End 2017 Financial Results

BioLineRx (BLRX) PT Lowered to $2 at Maxim Group

March 6, 2018 1:21 PM EST

Maxim Group lowered its price target on BioLineRx (NASDAQ: BLRX) to $2.00 (from $3.00) while maintaining a Buy rating.

Analyst Jason McCarthy commented, "BiolineRx reported 4Q17 with a net loss of $7.4M and ended the period with $50M in cash on the balance sheet,... More